Ligand Pharmaceuticals Inc financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 915 % -41.9%
Quick Ratio 29.4 % -71.6%
Debt-to-equity 25.5 % +99.9%
Return On Equity 5.71 % -1.38%
Return On Assets 4.55 % -11.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.7M shares +4.16%
Common Stock, Shares, Outstanding 19.7M shares +4.78%
Entity Public Float 1.1B USD +22.2%
Common Stock, Value, Issued 20K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 19.6M shares +6.29%
Weighted Average Number of Shares Outstanding, Diluted 20.6M shares +12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 251M USD +64.8%
Research and Development Expense 82.1M USD +265%
General and Administrative Expense 93M USD +34.7%
Operating Income (Loss) 17.5M USD +1648%
Nonoperating Income (Expense) 45.5M USD -39.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 63M USD +7.08%
Income Tax Expense (Benefit) 14.4M USD +6.1%
Net Income (Loss) Attributable to Parent 48.6M USD +7.38%
Earnings Per Share, Basic 2 USD/shares -14.9%
Earnings Per Share, Diluted 2 USD/shares -21.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139M USD +119%
Accounts Receivable, after Allowance for Credit Loss, Current 57.6M USD +67.7%
Inventory, Net 11.9M USD -28.9%
Other Assets, Current 6.99M USD -64.6%
Assets, Current 754M USD +144%
Deferred Income Tax Assets, Net 9.53M USD +12113%
Property, Plant and Equipment, Net 3.47M USD -77%
Operating Lease, Right-of-Use Asset 7.61M USD +6.32%
Intangible Assets, Net (Excluding Goodwill) 234M USD -15%
Goodwill 102M USD -3.52%
Other Assets, Noncurrent 2.77M USD -67%
Assets 1.48B USD +54.7%
Accounts Payable, Current 3.68M USD -21.6%
Employee-related Liabilities, Current 3.7M USD -3.5%
Accrued Liabilities, Current 24.1M USD +54.4%
Contract with Customer, Liability, Current 621K USD -46.1%
Liabilities, Current 30.5M USD +23.3%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 22.7M USD -51.1%
Operating Lease, Liability, Noncurrent 4.42M USD -29.6%
Other Liabilities, Noncurrent 19.9M USD -33.3%
Liabilities 527M USD +363%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9.32M USD +434%
Retained Earnings (Accumulated Deficit) 578M USD +9.08%
Stockholders' Equity Attributable to Parent 950M USD +13%
Liabilities and Equity 1.48B USD +54.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD -236%
Net Cash Provided by (Used in) Financing Activities -4.75M USD -139%
Net Cash Provided by (Used in) Investing Activities 4.89M USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 19.7M shares +4.78%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 27.1M USD -37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 139M USD +119%
Interest Paid, Excluding Capitalized Interest, Operating Activities 97K USD +64.4%
Deferred Tax Assets, Valuation Allowance 55.6M USD -3.55%
Deferred Tax Assets, Gross 96.3M USD -7.15%
Operating Lease, Liability 7.08M USD +15%
Payments to Acquire Property, Plant, and Equipment 214K USD +104%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 56.2M USD +17.2%
Lessee, Operating Lease, Liability, to be Paid 9.48M USD +7.57%
Property, Plant and Equipment, Gross 23.4M USD +5.12%
Operating Lease, Liability, Current 1.09M USD +2.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.64M USD +37.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.54M USD +46.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.98M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.63M USD +33.3%
Deferred Tax Assets, Operating Loss Carryforwards 40.4M USD -11.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 19.9M USD +37.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD +23.8%
Additional Paid in Capital 363M USD +17.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.77M USD +0.06%
Deferred Tax Assets, Net of Valuation Allowance 40.7M USD -11.7%
Interest Expense 557K USD -55.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%